Trial
NCT03061045
Contrast Enhanced Ultrasound Evaluation of Brain Perfusion in Neonatal Post-Hemorrhagic Hydrocephalus
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Johns Hopkins University
Collaborators
—
Condition
Neonatal Post-Hemorrhagic Hydrocephalus
Intervention
Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Intravenous Powder for Suspension [LUMASON]
Why stopped
PI is leaving the institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-25